Prenetics CEO and CFO buy $1 million in shares after Q2 results
Danny Yeung and Brian Rosin purchased shares between August 20 and 25, 2026, bringing leadership's cumulative investment since November 2025 to about $3.75 million.
SEC filing
Latest
6 stories
Wednesday, August 26
Thursday, August 20
Prenetics signs Lily Collins as IM8 ambassador, raises revenue guidance
The consumer health company added its first film and television ambassador as it lifted 2026 revenue guidance and issued a first 2027 forecast.
SEC filing
Tuesday, August 18
Prenetics reports IM8 revenue up 288% in Q2 2026, raises full-year guidance
The company said July was its strongest month yet for IM8 and its first month of positive consolidated adjusted free cash flow.
SEC filing
Monday, August 17
Prenetics names Caroline Levy independent director as IM8 parent readies Q2 results
The consumer health company appointed the veteran Wall Street analyst to its board on August 17, 2026, ahead of second-quarter earnings the following day.
SEC filing
Friday, August 7
Prenetics discloses terms of $1 billion IM8 financing with General Catalyst fund
A Form 6-K filed August 7, 2026 details the Customer Investment Agreement and guarantee backing IM8's growth spending, along with risk factors tied to the arrangement.
SEC filing
Tuesday, July 14
Prenetics' IM8 closes $1 billion growth financing from General Catalyst's CVF
Prenetics raised its 2026 IM8 revenue guidance to $210–220 million and said the non-dilutive facility will fund up to 70% of marketing spend.
SEC filing